16阳性HPV/ASC-H宫癌查结果是否比其他高风险HPV亚型更好地预测CIN 2+?
Abdurrahman Alp Tokalıoğlu1, Aysun Alcı2, Okan Oktar3
1Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara City Hospital, Ankara, Turkey.
Journal of the Turkish German Gynecological Association
|June 13, 2024
概括
高风险人类乳头瘤病毒 (HPV) 阳性,特别是HPV 16,与ASC-H细胞学患者的CIN 2+病变有显著的相关性. 这一发现凸显了HPV检测在管理ASC-H结果中对于早期检测高度发育不良的重要性.
科学领域:
- 妇科瘤学 妇科瘤学
- 宫病理学 宫病理学
- 病毒学 病毒学
背景情况:
- 非典型的状细胞,不能排除高度状细胞内瘤 (ASC-H) 是需要进一步调查的细胞学发现.
- 高风险人类乳头瘤病毒 (HPV) 测试在管理ASC-H病例中的作用需要澄清.
研究的目的:
- 调查高风险HPV类型与ASC-H细胞学患者宫内皮质瘤2级或更高 (CIN 2+) 病变的存在之间的相关性.
主要方法:
- 从2003年至2021年间接受了大肠镜检查的5271名患者的数据的回顾性分析.
- 专注于163名ASC-H细胞学患者,其中包括83例HPV阳性病例.
- 在HPV状态 (特别是HPV 16) 和最终病理学结果 (CIN 2+) 之间的相关性分析.
主要成果:
- 在患者年龄和CIN 2+病变之间没有发现显著的相关性 (p=0.053).
- 阳性HPV16 (单独或与其他类型一起) 显著增加了最终病理中CIN 2+病变的可能性.
- 在HPV16阳性ASC-H患者中,CIN 2+病变的概率为72.5%,而在HPV16阴性患者中为48.1% (p=0.033).
结论:
- 目前的指南缺乏在ASC-H管理中对HPV检测的全面定义.
- 积极的高风险HPV结果,特别是HPV 16,与ASC-H细胞学结合,表明高度发育不良的可能性更高.
- 对HPV检测,特别是对HPV 16的检测,是评估ASC-H病例中显著宫病理的风险的一个有价值的工具.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...


